Skip to main content
. 2021 Jun 30;13(7):2272. doi: 10.3390/nu13072272

Table 5.

Summary of changes in individual HMO concentrations throughout lactation.

Increasing over Lactation Decreasing over Lactation No Significant Trend
3-FL (3-Fucosyllactose)
3′S3FL		 2′-FL (2′-fucosyllactose)
LNT (Lacto-N-tetraose)
LNnT (Lacto-N-neotetraose)
LNFP I (Lacto-N-fucopentaose I)
Lacto-N-fucopentaose III (LNFP III)
Lacto-N-fucopentaose V (LNFP V)
3′-SL (α2,3-Sialyllactose) 1
6′-SL (α2,6-Sialyllactose)
LST a/b (Sialyllacto-N-tetraose)
LST c (Sialyllacto-N-neotetraose)		 LDFT (Lactodifucotetraose)
LNFP II (Lacto-N-fucopentaose II)
A-Tetra
LNnFP II (Lacto-N-neofucopentaose II)
DSLNT

1 Results from Ma et al., (2018) [25] study and Huang et al., (2019) [24] study showed 3′-SL increased throughout lactation in Malaysia and Chinese human milk.